Rezultati pretrage autora

1

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control od Ketteler, Markus

Izdano 2011

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
2

14. Recent Approaches to Therapy: Is There Real Progress? od Ketteler, Markus

Izdano 2009

Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
3

Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease od Ketteler, Markus, Ambühl, Patrice

Izdano 2021

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
4

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future od Brandenburg, Vincent, Ketteler, Markus

Izdano 2022

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
5

Evolving Calciphylaxis—What Randomized, Controlled Trials Can Contribute to the Capture of Rare Diseases od Ketteler, Markus, Biggar, Patrick H.

Izdano 2015

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
6

Magnesium basics od Jahnen-Dechent, Wilhelm, Ketteler, Markus

Izdano 2012

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
7

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency od Ketteler, Markus, Brandenburg, Vincent Matthias

Izdano 2017

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
8

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease od Fouque, Denis, Vervloet, Marc, Ketteler, Markus

Izdano 2018

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
9

Management of hyperphosphataemia in chronic kidney disease—challenges and solutions od Ketteler, Markus, Wüthrich, Rudolf P., Floege, Jürgen

Izdano 2013

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
10

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons od Di Iorio, Biagio Raffaele, Ketteler, Markus, Russo, Domenico, Wang, Angela

Izdano 2011

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
11

Atypical case of AL amyloidosis with urinary erythrocyte casts od Liangos, Orfeas, Buettner-Herold, Maike, Ketteler, Markus, Madias, Nicolaos E.

Izdano 2015

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
12

Phosphate Additives in Food—a Health Risk od Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes

Izdano 2012

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
13

Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis od Oberacker, Tina, Fritz, Peter, Schanz, Moritz, Alscher, Mark Dominik, Ketteler, Markus, Schricker, Severin

Izdano 2022

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
14

Ecto-5' -Nucleotidase CD73 (NT5E), vitamin D receptor and FGF23 gene polymorphisms may play a role in the development of calcific uremic arteriolopathy in dialysis patients – Data... od Rothe, Hansjörg, Brandenburg, Vincent, Haun, Margot, Kollerits, Barbara, Kronenberg, Florian, Ketteler, Markus, Wanner, Christoph

Izdano 2017

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
15

Association Between Human Fetuin-A and the Metabolic Syndrome Data From the Heart and Soul Study od Ix, Joachim H., Shlipak, Michael G., Brandenburg, Vincent M., Ali, Sadia, Ketteler, Markus, Whooley, Mary A.

Izdano 2006

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
16

Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide od Covic, Adrian C., Floege, Jürgen, Ketteler, Markus, Sprague, Stuart M., Lisk, Laura, Rakov, Viatcheslav, Rastogi, Anjay

Izdano 2017

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
17

Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation od Floege, Jürgen, Funk, Felix, Ketteler, Markus, Rastogi, Anjay, Walpen, Sebastian, Covic, Adrian C, Sprague, Stuart M

Izdano 2020

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
18

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study od Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen

Izdano 2020

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
19

Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study od Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Izdano 2007

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:
20

Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study od Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Izdano 2006

Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
Tekst

Spremi u popis

Spremljeno u:

Rezultati pretrage - Ketteler, Markus

Phosphate Metabolism in CKD Stages 3–5: Dietary and Pharmacological Control od Ketteler, Markus

14. Recent Approaches to Therapy: Is There Real Progress? od Ketteler, Markus

Where are we now? Emerging opportunities and challenges in the management of secondary hyperparathyroidism in patients with non-dialysis chronic kidney disease od Ketteler, Markus, Ambühl, Patrice

Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future od Brandenburg, Vincent, Ketteler, Markus

Evolving Calciphylaxis—What Randomized, Controlled Trials Can Contribute to the Capture of Rare Diseases od Ketteler, Markus, Biggar, Patrick H.

Magnesium basics od Jahnen-Dechent, Wilhelm, Ketteler, Markus

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency od Ketteler, Markus, Brandenburg, Vincent Matthias

Targeting Gastrointestinal Transport Proteins to Control Hyperphosphatemia in Chronic Kidney Disease od Fouque, Denis, Vervloet, Marc, Ketteler, Markus

Management of hyperphosphataemia in chronic kidney disease—challenges and solutions od Ketteler, Markus, Wüthrich, Rudolf P., Floege, Jürgen

The Phosphorus and the Vascular Calcification in ESRD between Old Adventures and New Horizons od Di Iorio, Biagio Raffaele, Ketteler, Markus, Russo, Domenico, Wang, Angela

Atypical case of AL amyloidosis with urinary erythrocyte casts od Liangos, Orfeas, Buettner-Herold, Maike, Ketteler, Markus, Madias, Nicolaos E.

Phosphate Additives in Food—a Health Risk od Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes

Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis od Oberacker, Tina, Fritz, Peter, Schanz, Moritz, Alscher, Mark Dominik, Ketteler, Markus, Schricker, Severin

Association Between Human Fetuin-A and the Metabolic Syndrome Data From the Heart and Soul Study od Ix, Joachim H., Shlipak, Michael G., Brandenburg, Vincent M., Ali, Sadia, Ketteler, Markus, Whooley, Mary A.

Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide od Covic, Adrian C., Floege, Jürgen, Ketteler, Markus, Sprague, Stuart M., Lisk, Laura, Rakov, Viatcheslav, Rastogi, Anjay

Iron kinetics following treatment with sucroferric oxyhydroxide or ferric citrate in healthy rats and models of anaemia, iron overload or inflammation od Floege, Jürgen, Funk, Felix, Ketteler, Markus, Rastogi, Anjay, Walpen, Sebastian, Covic, Adrian C, Sprague, Stuart M

Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study od Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen

Association of Fetuin-A With Mitral Annular Calcification and Aortic Stenosis Among Persons With Coronary Heart Disease: Data From the Heart and Soul Study od Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study od Ix, Joachim H., Chertow, Glenn M., Shlipak, Michael G., Brandenburg, Vincent M., Ketteler, Markus, Whooley, Mary A.

Alati za pretragu: